Endocrine Pharmacology Practice Questions

Q: All of the following are risk factors for increased lactic acidosis in patients on metformin therapy except?

Smoking. **Explanation:** Metformin, a biguanide, is the first-line treatment for Type 2 Diabetes Mellitus. Its most serious, though rare, side effect is **Metformin-Associated Lactic Acidosis (MALA)**. This occurs because metformin inhibits mitochondrial glycerophosphate dehydrogenase and complex I of the electron transport chain, leading to decreased gluconeogenesis from lactate and a subsequent shift toward anaerobic metabolism. **Why Smoking is the Correct Answer:** Smoking is not a risk factor for lactic acidosis. While smoking increases cardiovascular risk in diabetics, it does not interfere with the metabolic clearance of metformin or the production/clearance of lactate. **Why the other options are incorrect:** * **Renal Dysfunction (Option C):** This is the **most significant** risk factor. Metformin is excreted unchanged by the kidneys. Impaired renal function (typically eGFR <30 ml/min) leads to drug accumulation and toxic levels, precipitating lactic acidosis. * **Liver Dysfunction (Option B):** The liver is the primary organ responsible for lactate clearance (via the Cori cycle). Hepatic impairment reduces the body's ability to utilize lactate, increasing the risk of accumulation. * **Advanced Age (Option A):** Elderly patients often have a physiological decline in GFR and are more prone to episodes of dehydration or heart failure, indirectly increasing the risk of metformin accumulation and tissue hypoxia. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism:** Activates AMP-activated protein kinase (AMPK), decreasing hepatic glucose production. 2. **Contraindication:** Metformin should be withheld before major surgery or IV contrast studies (due to risk of contrast-induced nephropathy). 3. **Vitamin Deficiency:** Long-term use is associated with **Vitamin B12 deficiency** (megaloblastic anemia). 4. **Weight Effect:** It is weight-neutral or causes modest weight loss, unlike sulfonylureas or insulin.

Q: Danazol is a/an:

Androgen agonist. ### Explanation **Correct Option: B (Androgen agonist)** Danazol is a synthetic ethisterone derivative that acts as a **weak androgen agonist**. Its primary mechanism of action involves binding to androgen, progesterone, and glucocorticoid receptors. In the context of the hypothalamic-pituitary-ovarian axis, it suppresses the mid-cycle surge of LH and FSH (gonadotropin inhibition), leading to a state of "pseudomenopause." This makes it effective in treating endometriosis and fibrocystic breast disease. Additionally, it increases the levels of C1 esterase inhibitor, making it the drug of choice for prophylaxis in hereditary angioedema. **Why other options are incorrect:** * **A. Anabolic steroid:** While Danazol has weak androgenic properties, it is not classified as a primary anabolic steroid (like Stanozolol or Oxandrolone) used for muscle wasting or weight gain. * **C. Anti-androgen:** Danazol exerts androgenic effects rather than blocking them. Examples of anti-androgens include Flutamide or Spironolactone. * **D. 5-alpha-reductase inhibitor:** These drugs (e.g., Finasteride, Dutasteride) inhibit the conversion of testosterone to dihydrotestosterone (DHT). Danazol does not interfere with this enzyme. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Prophylaxis of **Hereditary Angioedema** (increases C1 esterase inhibitor levels). * **Side Effects:** Weight gain, acne, hirsutism, and deepening of voice (due to its androgenic nature). * **Contraindication:** Pregnancy (Category X) due to the risk of virilization of a female fetus. * **Other uses:** Endometriosis, Menorrhagia, and Immune Thrombocytopenic Purpura (ITP).

Q: Which of the following insulins has the longest duration of action?

Protamine-zinc insulin. **Explanation:** The duration of action of insulin preparations is primarily determined by their rate of absorption from the subcutaneous site, which is influenced by the physical state (crystalline vs. amorphous) and the addition of retarding agents like zinc or protamine. **Why Protamine-Zinc Insulin (PZI) is correct:** PZI is a **long-acting (ultralente)** insulin. It contains a high concentration of both protamine and zinc, which leads to the formation of large, poorly soluble complexes. These complexes dissociate very slowly at the injection site, resulting in a prolonged duration of action, typically exceeding **24 to 36 hours**. Among the options provided, it has the slowest onset and the longest duration. **Analysis of Incorrect Options:** * **Neutral Protamine Hagedorn (NPH):** Also known as Isophane insulin, this is an **intermediate-acting** insulin. It contains stoichiometric amounts of protamine and has a duration of approximately 12–18 hours. * **Insulin-Zinc Suspension (Lente):** This is a mixture of 70% crystalline (ultralente) and 30% amorphous (semilente) insulin. It is **intermediate-acting** with a duration of 18–24 hours. * **Global Zinc Suspension:** This is a less common term, but zinc suspensions generally fall into intermediate or long-acting categories depending on the crystal size; however, they do not exceed the duration provided by the protamine-zinc combination. **High-Yield NEET-PG Pearls:** * **Ultra-Short Acting (Rapid):** Lispro, Aspart, Glulisine (Mnemonic: **L**ispro **A**spart **G**lulisine = **LAG**). * **Longest Acting (Modern Analogues):** **Degludec** (>42 hours) is currently the longest-acting insulin analogue, followed by Glargine (U-300). * **Protamine Caution:** Protamine-containing insulins (NPH, PZI) should **never** be given intravenously; they are for subcutaneous use only. * **Glargine:** Known as "peakless" insulin because it provides a steady basal level.

Q: Which phosphodiesterase inhibitor is used for erectile dysfunction?

Sildenafil. **Explanation:** **Sildenafil** is the correct answer because it is a selective inhibitor of **Phosphodiesterase-5 (PDE-5)**. In the corpus cavernosum of the penis, sexual stimulation leads to the release of Nitric Oxide (NO), which activates guanylyl cyclase to produce **cyclic GMP (cGMP)**. cGMP causes smooth muscle relaxation and increased blood flow, leading to an erection. PDE-5 is the enzyme responsible for the degradation of cGMP. By inhibiting PDE-5, Sildenafil prevents the breakdown of cGMP, thereby enhancing and prolonging the erectile response. **Analysis of Incorrect Options:** * **Amrinone & Milrinone:** These are **PDE-3 inhibitors**. They increase cAMP levels in cardiac myocytes and vascular smooth muscle. They are used as inotropic agents in the short-term management of acute heart failure, not for erectile dysfunction. * **Tamoxifen:** This is a **Selective Estrogen Receptor Modulator (SERM)**. It acts as an antagonist in breast tissue and is used in the treatment and prevention of breast cancer. It has no effect on phosphodiesterase enzymes. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindication:** Sildenafil must **never** be co-administered with **Nitrates** (e.g., Nitroglycerin) as it can lead to life-threatening hypotension due to synergistic increases in cGMP. * **Side Effects:** Common side effects include headache, flushing, and **cyanopsia** (blue-tinted vision) due to cross-inhibition of PDE-6 in the retina. * **Other PDE-5 Inhibitors:** Tadalafil (longer half-life, "the weekend pill") and Vardenafil. * **Other Indications:** Sildenafil is also FDA-approved for the treatment of **Pulmonary Arterial Hypertension (PAH)**.

Q: Medical castration is effected by which of the following?

LH RH analogues. **Explanation:** **Medical castration** refers to the use of drugs to reduce serum testosterone levels to castrate levels (typically <50 ng/dL), achieving the same hormonal effect as a bilateral orchiectomy (surgical castration). **Why LH-RH Analogues are correct:** LH-RH (GnRH) analogues like **Leuprolide, Goserelin, and Nafarelin** are the mainstay for medical castration. * **Mechanism:** Initially, they cause a transient "flare" of LH and FSH. However, continuous administration leads to the **downregulation and desensitization of GnRH receptors** in the pituitary gland. * **Result:** This suppresses the secretion of LH and FSH, leading to a profound drop in testosterone production by the Leydig cells in the testes. **Analysis of Incorrect Options:** * **A. Diethylstilbesterol (DES):** A synthetic estrogen formerly used for prostate cancer. While it suppresses the hypothalamic-pituitary-gonadal axis, it is no longer the preferred method for medical castration due to significant cardiovascular toxicity and thromboembolic risks. * **C. Gossypol:** A polyphenolic compound derived from cottonseed. It is studied as a **male contraceptive** because it inhibits sperm production (spermatogenesis) and motility, but it does not achieve castrate levels of testosterone. * **D. Hanovan:** This is not a standard pharmacological agent used in endocrine therapy or medical castration. **High-Yield Clinical Pearls for NEET-PG:** * **Flare Phenomenon:** To prevent the initial testosterone surge (flare) caused by GnRH agonists, they are often co-administered with **Flutamide** (an androgen receptor antagonist) for the first few weeks of therapy. * **GnRH Antagonists:** Drugs like **Degarelix and Abarelix** achieve medical castration more rapidly than agonists without causing a testosterone flare. * **Indications:** Medical castration is primarily used in the management of **Advanced Prostate Cancer**.

Q: Metformin is used as an antihyperglycemic agent in Diabetes Mellitus. Which of the following are considered off-label or additional uses of Metformin, EXCEPT?

Alcoholic fatty liver disease. **Explanation:** Metformin, a biguanide, is the first-line drug for Type 2 Diabetes Mellitus. Its primary mechanism involves activating **AMP-activated protein kinase (AMPK)**, which leads to decreased hepatic gluconeogenesis and improved peripheral insulin sensitivity. **Why Option C is the Correct Answer:** Metformin has **no proven clinical benefit** in treating **Alcoholic Fatty Liver Disease (AFLD)**. The pathogenesis of AFLD is driven by ethanol metabolism and oxidative stress rather than primary insulin resistance. Furthermore, chronic alcohol consumption is a major risk factor for **lactic acidosis** (a rare but fatal side effect of Metformin) because both alcohol and Metformin increase the lactate-to-pyruvate ratio. Therefore, Metformin is generally avoided or used with extreme caution in patients with significant alcohol intake. **Analysis of Other Options (Off-label/Additional Uses):** * **A. Polycystic Ovarian Disease (PCOD):** Metformin is widely used to improve insulin sensitivity, which reduces hyperinsulinemia. This helps restore ovulation and reduces androgen levels. * **B. Non-alcoholic Fatty Liver Disease (NAFLD):** Since NAFLD is the hepatic manifestation of metabolic syndrome and insulin resistance, Metformin is often used to improve biochemical markers (though its effect on liver histology is limited). * **D. HIV-associated Metabolic Abnormalities:** Metformin is used to manage lipodystrophy and insulin resistance associated with Highly Active Antiretroviral Therapy (HAART). **High-Yield NEET-PG Pearls:** * **DOC:** Metformin is the drug of choice for obese diabetics. * **Weight Neutral/Loss:** Unlike sulfonylureas or insulin, Metformin does not cause weight gain. * **Vitamin Deficiency:** Long-term use can lead to **Vitamin B12 deficiency** (megaloblastic anemia). * **Contraindication:** Avoid if eGFR is **<30 mL/min/1.73 m²** due to the risk of lactic acidosis.

Q: Which of the following drugs does not cause hypoglycemia?

Metformin. The key to answering this question lies in distinguishing between **insulin secretagogues** and **euglycemic agents (insulin sensitizers).** **1. Why Metformin is the Correct Answer:** Metformin belongs to the **Biguanide** class. Its primary mechanism of action is to decrease hepatic glucose production (gluconeogenesis) and improve peripheral insulin sensitivity. Crucially, Metformin **does not stimulate insulin release** from the pancreatic beta cells. Because it does not increase circulating insulin levels beyond physiological needs, it does not cause hypoglycemia when used as monotherapy. It is therefore classified as a "euglycemic" agent. **2. Why the Other Options are Incorrect:** * **Tolbutamide (Option A), Glibenclamide (Option B), and Chlorpropamide (Option D)** are all **Sulfonylureas** [1]. * **Mechanism:** They act by blocking ATP-sensitive K⁺ channels in the pancreatic beta-cell membrane [2]. This leads to depolarization, Ca²⁺ influx, and the **forced release of insulin**, regardless of the prevailing blood glucose level [2]. * Because they trigger insulin secretion even when blood sugar is normal, **hypoglycemia** is their most common and significant side effect [3]. **3. NEET-PG High-Yield Clinical Pearls:** * **Drug of Choice:** Metformin is the first-line drug for Type 2 Diabetes Mellitus and is weight-neutral or leads to weight loss. * **Side Effects:** The most serious (though rare) side effect of Metformin is **Lactic Acidosis**; it is contraindicated in renal failure (CrCl <30 ml/min). * **Long-acting Sulfonylureas:** Chlorpropamide has the longest half-life and is most notorious for causing prolonged hypoglycemia and a disulfiram-like reaction with alcohol. * **Other Euglycemic classes:** Pioglitazone (Thiazolidinediones) and DPP-4 inhibitors (Gliptins) also have a low risk of hypoglycemia.

Q: What is the drug of choice for central diabetes insipidus?

Desmopressin. **Explanation:** **Desmopressin (dDAVP)** is the drug of choice for **Central Diabetes Insipidus (CDI)**. CDI is characterized by a deficiency of Antidiuretic Hormone (ADH) from the posterior pituitary. Desmopressin is a synthetic analogue of vasopressin with two key modifications: it has a longer half-life and is a **selective V2 receptor agonist**. By acting on V2 receptors in the renal collecting ducts, it increases water reabsorption without causing the significant vasoconstriction associated with V1 receptor activation. It can be administered intranasally, orally, or parenterally. **Analysis of Incorrect Options:** * **Vasopressin (ADH):** While it is the endogenous hormone, it is not the drug of choice because it acts non-selectively on both V1 (vasoconstriction) and V2 receptors. It has a very short duration of action (15–20 minutes), requiring frequent dosing, and carries a risk of hypertension and myocardial ischemia. * **Lypressin:** This is a synthetic analogue (8-lysine vasopressin) formerly used for CDI. However, it has a shorter duration of action and less potency compared to Desmopressin, making it obsolete in modern practice. * **Presselin:** This is not a standard pharmacological agent used in the treatment of Diabetes Insipidus. **High-Yield Clinical Pearls for NEET-PG:** * **V2 Selectivity:** Desmopressin has a V2:V1 selectivity ratio of approximately 2000:1. * **Other Uses of Desmopressin:** It is also the drug of choice for **Nocturnal Enuresis** and is used in **Von Willebrand Disease (Type 1)** and **Hemophilia A** because it stimulates the release of Factor VIII and vWF from endothelial cells. * **Diagnosis:** To differentiate Central from Nephrogenic DI, a **Water Deprivation Test** followed by Desmopressin administration is used; a significant increase in urine osmolality indicates Central DI.

Question 1

Which of the following drugs produces neutrophilia?

Accepted Answer

Glucocorticoids

Answer

Chlorambucil

Answer

Sulfonamides

Answer

Chloramphenicol

Question 2

All of the following are risk factors for increased lactic acidosis in patients on metformin therapy except?

Accepted Answer

Smoking

Answer

Advanced age

Answer

Liver dysfunction

Answer

Renal dysfunction

Question 3

Danazol is a/an:

Accepted Answer

Androgen agonist

Answer

Anabolic steroid

Answer

Anti-androgen

Answer

5-alpha-reductase inhibitor

Question 4

Which of the following insulins has the longest duration of action?

Accepted Answer

Protamine-zinc insulin

Answer

Global zinc suspension

Answer

Insulin-zinc suspension

Answer

Neutral protamine Hagedorn (NPH) insulin

Question 5

Which phosphodiesterase inhibitor is used for erectile dysfunction?

Accepted Answer

Sildenafil

Answer

Amrinone

Answer

Milrinone

Answer

Tamoxifen

Question 6

Medical castration is effected by which of the following?

Accepted Answer

LH RH analogues

Answer

Diethylstilbesterol

Answer

Gossypol

Answer

Hanovan

Question 7

Metformin is used as an antihyperglycemic agent in Diabetes Mellitus. Which of the following are considered off-label or additional uses of Metformin, EXCEPT?

Accepted Answer

Alcoholic fatty liver disease

Answer

Polycystic Ovarian Disease (PCOD)

Answer

Non-alcoholic fatty liver disease

Answer

Metabolic abnormalities associated with HIV disease

Question 8

Which of the following drugs does not cause hypoglycemia?

Accepted Answer

Metformin

Answer

Tolbutamide

Answer

Glibenclamide

Answer

Chlorpropamide

Question 9

What is the drug of choice for central diabetes insipidus?

Accepted Answer

Desmopressin

Answer

Vasopressin

Answer

Lypressin

Answer

Presselin

Question 10

A 55-year-old woman undergoing tamoxifen therapy for breast cancer presents with vaginal bleeding. What is the best explanation for this symptom?

Accepted Answer

Tamoxifen has an antagonist effect on the breast but an agonist effect on the uterus.

Answer

Tamoxifen acts as an estrogen antagonist in both the breast and uterus, leading to a loss of endometrial cells.

Answer

Tamoxifen has an estrogen agonist effect on both the breast and uterus, leading to endometrial hyperplasia.

Answer

Tamoxifen has no effect on the uterus, and the vaginal bleeding is caused by an unrelated condition.

Endocrine Pharmacology — MCQs

Endocrine Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?